Raymond James Financial Inc Pacira Bio Sciences, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 10,099 shares of PCRX stock, worth $273,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,099Holding current value
$273,581% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PCRX
# of Institutions
252Shares Held
48.6MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$144 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.26MShares$88.4 Million0.15% of portfolio
-
State Street Corp Boston, MA2.01MShares$54.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$53.6 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.24B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...